NLA Resources
Hypertriglyceridemia
12 Resources
Knowledge Center
The National Lipid Association is your destination for the science of lipid medicine. Now, everything we know is in one place.
Hypertriglyceridemia
12 Available Resources
The Lipid Panel – Hypertriglyceridemia
The Lipid Panel – Hypertriglyceridemia in Patients with T2DM
Icosapent Ethyl-Treated Hypertriglyceridemia to Reduce ASCVD Residual Risk
The Reduction of Cardiovascular Events with Icosapent Ethyl Intervention Trial (REDUCE-IT) as authored by Bhatt, DL et al, shows strong…
Practical Pearls – TG-Targets ApoC3 & ANGPTL3
National Lipid Association Scientific Statement on the use of icosapent ethyl in statin-treated patients with elevated triglycerides and high or very-high ASCVD risk
National Lipid Association Scientific Statement on the use of icosapent ethyl in statin-treated patients with elevated triglycerides and high or…
Hypertriglyceridemia and the Risk of Cardiovascular Disease and Pancreatitis in a Veteran Population
The Veterans Health Administration (VA) is the nation’s largest integrated health care delivery system serving more than 11 million patients.…
Practical Approaches to Dietary Management of Hypertriglyceridemia
Nutrition Recommendations for HypertriglyceridemiaHigh triglycerides (TG) are a target for atherosclerotic cardiovascular disease (ASCVD) risk reduction.1-5 Despite the use of…
Therapies for Treating Hypertriglyceridemia
Many observational studies have established a link between elevated triglycerides and adverse cardiovascular events.1 Experimental and Mendelian randomization studies have…
Familial Chylomicronemia Syndrome: An Expert Clinical Review from the National Lipid Association
Familial Chylomicronemia Syndrome: An Expert Clinical Review from the National Lipid Association
Management of Hypertriglyceridemia in a Patient Considered an Undocumented Immigrant
IntroductionThe management of elevated triglycerides is a means by which the burden of Atherosclerotic Cardiovascular Disease(ASCVD) may be reduced and…
Renewed Justification for Triglyceride-Lowering Therapy: Insight from REDUCE-IT and Previous Fibrate Trials
An accumulating body of evidence has implicated hypertriglyceridemia as a treatable risk factor for the prevention of atherosclerotic cardiovascular diseases…
Severe Hypertriglyceridemia in a 40-Year-Old Woman: Using the ApoB App to Confirm a Diagnosis and Target Future Cardiovascular Risk
Case History Mary is a 40-year-old school teacher who was referred for severe elevation of triglycerides (TGs). She has a…
Join the NLA
Become A Member
When you become a member of the NLA, you become part of a collegial multidisciplinary group of leaders dedicated to improving lipid and cardiometabolic health.
